Cytotoxic Chemotherapy
134 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.
Cytotoxic Chemotherapy (134)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Cytarabine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Cytarabine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Cytosine Arabinoside Ocfosfate |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Cytosine Arabinoside Ocfosfate
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Dacarbazine |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Dacarbazine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
Dactinomycin |
Antitumour Antibiotic | Solid Tumour | ||
|
Molecule
Dactinomycin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Antitumour Antibiotic |
||||
Daunorubicin |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Daunorubicin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Decitabine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Decitabine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Decitabine + Cedazuridine (Oral Fixed-Dose) |
Oral Hypomethylating Agent + Cytidine Deaminase Inhibitor | Hematologic (MDS/AML) | ||
|
Molecule
Decitabine + Cedazuridine (Oral Fixed-Dose)
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Hematologic (MDS/AML)
Drug Class / Mechanism
Oral Hypomethylating Agent + Cytidine Deaminase Inhibitor |
||||
Decitabine-Cedazuridine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Decitabine-Cedazuridine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Dicycloplatin |
Platinum Compound | Solid Tumour | ||
|
Molecule
Dicycloplatin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
||||
Diflomotecan |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Diflomotecan
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Docetaxel |
Antimicrotubule Agent | Both (Solid & Hematologic) | ||
|
Molecule
Docetaxel
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
||||
Doxifluridine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Doxifluridine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
CytarabineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
Cytosine Arabinoside OcfosfateCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
DacarbazineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|
DactinomycinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Antitumour Antibiotic |
|
DaunorubicinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
DecitabineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
Decitabine + Cedazuridine (Oral Fixed-Dose)Cytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Hematologic (MDS/AML)
Drug Class / Mechanism
Oral Hypomethylating Agent + Cytidine Deaminase Inhibitor |
|
Decitabine-CedazuridineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
DicycloplatinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
|
DiflomotecanCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
DocetaxelCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
|
DoxifluridineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|